Aspartate proteases are a group of protein hydrolases that share the same catalytic apparatus. Members of the aspartate protease family can be found in a variety of organisms, from humans to plants and retroviruses. They play a crucial role in certain disease processes: hypertension, Alzheimer's disease, HIV, malaria, diabetes or fungal infections. The best known sources of aspartic proteases are the mammalian stomach, yeast and fungi, with porcine pepsin being the original type. Aspartate proteases are one of four classes of proteolytic enzymes that are capable of cutting other proteins into smaller pieces. Protein hydrolases are known as peptidases and proteases. In the aspartic proteases, two aspartic acids make up the catalytic mechanism of the enzyme. Unlike other proteases in their protease family, naturally occurring aspartate protease inhibitors are relatively rare. Scientists have studied the detailed mechanisms of protease activity inhibition with the aim of discovering new aspartic protease modulators.
BOC Sciences is capable of designing a screening set based on 2D similarity methods.
Figure 1. Possible roles played by aspartic-type peptidases produced by human pathogenic trypanosomatids. (Santos, L.; et al. 2013)
BOC Sciences has developed this unique library by employing a 2D similarity approach to provide more than 1,400 drug-like screening compounds.
Here are drug targets used for the 2D similarity-based aspartic protease focused library:
BOC Sciences provides professional, rapid and high-quality services of 2D Similarity-based Aspartic Protease Focused Library design at competitive prices for global customers. Personalized and customized services of 2D Similarity-based Aspartic Protease Focused Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.